Spain Archives

som biotech huntingtons disease repurpose amyloidosis

Startup Scout 29 Mar 2019

This Biotech Repurposes Drugs to Fight Huntington’s Disease

Barcelona-based SOM Biotech is developing treatments for incurable diseases such as Huntington’s disease with drugs that are already on the market for other diseases. Mission: To repurpose commercially available drugs for the treatment of neurological diseases lacking effective treatments. Using existing drugs to treat these rare, orphan diseases lets the company get the treatments to […]

March 29, 2019 - 4 minutesmins - By Jonathan Smith

silk fibroin biomaterial stroke stem cells

News and Trends 19 Nov 2018

Silk Biomaterial Could Regenerate the Brain After a Stroke

A group of researchers in Spain has developed a silk biomaterial that can increase the survival of transplanted stem cells into the brain, improving recovery after a stroke or brain injury. The nervous system has limited capacity to recover after an injury, such as those produced by a stroke or brain trauma. Stem cell transplants […]

November 19, 2018 - 4 minutesmins - By Clara Rodríguez Fernández

More News! 29 Oct 2018

Plasma Replacement Therapy Promising in Alzheimer’s Patients

A blood plasma replacement therapy from Spanish company Grifols reduced cognitive decline by 61% in patients with moderate Alzheimer’s disease compared with placebo. The researchers monitored the cognitive symptoms of 496 patients with Alzheimer’s disease in the Phase IIb/III trial. Over 14 months, the therapy had no effect in patients with mild Alzheimer’s, but the […]

October 29, 2018 - 2 minutesmins - By Jonathan Smith

Aelix Therapeutics Gilead Functional HIV Cure

News and Trends 19 Oct 2018

Spanish Biotech Partners Gilead to Develop Functional HIV Cure

AELIX Therapeutics and Gilead will run a clinical trial testing a combination of treatments that has potential to let HIV-infected people ditch lifelong therapy. The trial, which will run in Spain, is planned to start in early 2019 and will recruit around 90 patients in the early stages of HIV infection. After receiving the […]

October 19, 2018 - 2 minutesmins - By Clara Rodríguez Fernández

In Depth 8 Oct 2018

Behind the Scenes of the Spanish Biotech Industry’s Boom

The Spanish biotech industry is booming, but from my conversations with industry players elsewhere in Europe, it seems the country’s biotech industry keeps being a mystery for many. I caught up with experts at the Biospain conference to draw an overview of how biotech in Spain is doing in 2018. When we talk about biotech […]

October 8, 2018 - 5 minutesmins - By Clara Rodríguez Fernández

News and Trends 31 Jul 2018

Recycled Forestry Waste Could Make Cosmetics, Plastics and Biofuel

An EU project is using forestry waste to make 2,3-butanediol, a chemical with a wide range of industrial applications, from perfumes to synthetic rubber and food additives. Rehap, an EU project, has found a way to produce 2,3-butanediol, a chemical building block used in a range of industrial applications, using sugars purified from forestry waste. […]

July 31, 2018 - 2 minutesmins - By Alexander Burik

News and Trends 30 Jul 2018

This Transgenic Rice Could Prevent HIV Infections

Researchers in Spain have created a strain of genetically-engineered rice that could provide a cheap alternative to produce medicines for HIV prevention. The risk of HIV infections can be significantly reduced with oral medication. However, pricing is a big issue for people living in impoverished or developing countries who are at risk. Researchers at the […]

July 30, 2018 - 3 minutesmins - By Clara Rodríguez Fernández

More News! 30 Jul 2018

We May Soon Diagnose Traumatic Brain Injury With a Single Drop of Blood

Swiss and Spanish researchers are developing a diagnostic test that measures the severity of mild traumatic brain injury that delivers results in ten minutes with a single drop of blood. CT scans are currently the only reliable method for diagnosing mild traumatic brain injury. However, the technology is not available in all hospitals, is expensive […]

July 30, 2018 - 3 minutesmins - By Alexander Burik

More News! 18 May 2018

New Treatment for Rare Neurologic Eye Disease on Horizon from Spanish Biotech

Spanish biotech Bionure has started an early stage trial of a new drug to treat rare neurologic eye diseases, which also shows promise for treatment of multiple sclerosis and other similar conditions. The therapy (BN201) is the first its class and if successful in clinical trials will be the only treatment that can help repair […]

May 18, 2018 - 2 minutesmins - By Helen Albert

Startup Scout 6 Apr 2018

Spanish Biotech Uses Microbes to Make Biofuels, Food and Detergents

Today, we’re in Granada, Spain, to visit Neol Bio. The biotech recycles waste to produce oils for biofuels, nutritional supplements and cleaning detergents by culturing microorganisms with waste. Mission: Neol Bio develops sustainable ways of producing oils for a wide variety of applications, from food supplements to cleaning detergents and bioenergy. The company uses high-throughput screening to […]

April 6, 2018 - 2 minutesmins - By Alexander Burik

Spanish Research Stem Cell ALS Treatment

News and Trends 19 Mar 2018

Early Research in Bone Marrow Transplants Could Treat ALS

Early stage research from Spain could lead to a treatment for amyotrophic lateral sclerosis (ALS) using adult stem cells from bone marrow to stop progressive muscle paralysis. Researchers from the Neuroscience Institute at the Universidad Miguel Hernández (UMH) in Elche, Alicante, and the Spanish National Research Council (CSIC) aim to test a stem cell treatment for […]

March 19, 2018 - 3 minutesmins - By Alexander Burik

News and Trends 7 Mar 2018

This Spanish Biotech Might Have the First Effective Treatment for a Rare Blood Condition

Sanifit has successfully completed a Phase II trial with what could be the first effective treatment for calciphylaxis, a deadly rare disease caused by calcium accumulation in the blood. Mallorca-based Sanifit is targeting calciphylaxis with its treatment called SNF472. Results from Sanifit’s Phase II trial show that the drug promotes wound healing and reduces pain, though the details […]

March 7, 2018 - 3 minutesmins - By Alexander Burik

Resources

Categories

The twelve hottest biotech companies in the Boston area

Biotech bankruptcies: what to expect in 2024 following a record year?

Approaches

Therapeutic areas

RNA editing set to take off: could it outperform gene editing?

Future of cancer treatment: what will therapy look like in 2034?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us